| abstract |
The present invention provides novel imidazo [4,5-c] quinoline derivatives of formula I, and pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are as defined herein. is there). The present invention is also directed to a pharmaceutical composition comprising a compound of formula I and the use of the compound in the treatment of a disease associated with LRRK2, for example a neurodegenerative disease such as Parkinson's disease or Alzheimer's disease, cancer, Crohn's disease or leprosy. To be |